Why Moderna stock plunged despite positive cancer vaccine trail results?

Moderna shares MRNA plunged on Thursday after partial data from its closely watched cancer vaccine trial leaked ahead of a scheduled presentation at the European Society for Medical Oncology conferenc...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。